(Paperback, Revised edition)
By: Paul Rabinow
ISBN: 9780691126142
Readership/Audience: Professional and Scholarly
Publication Date: Jun 2006
Publisher: Princeton University Press
See more...
Represents an original look at the biotechnology research in the wake of the mapping of the human genome. Presenting a series of interviews with various key players in Celera Diagnostics, this title opens a window on the complexity of corporate scientific innovation.
(Hardback)
Readership/Audience: Tertiary Education
Publication Date: Nov 1992
Publisher: Bloomsbury Publishing PLC
See more...
(Paperback, Main)
By: Billy Kenber
ISBN: 9781838850296
Readership/Audience: Tertiary Education
Publication Date: Oct 2022
UK Publication Date: 7th July 2022
Publisher: Canongate Books
See more...
An urgent call to build a new model for the pharmaceutical industry, from the multi-award-winning Times journalist.
(Hardback)
By: Elizabeth Chiarello
ISBN: 9780691224770
Readership/Audience: Tertiary Education
Publication Date: Jan 2025
Publisher: Princeton University Press
See more...
(Hardback)
By: Gordon Binder
ISBN: 9781591398615
Readership/Audience: General
Publication Date: Apr 2008
Publisher: Harvard Business Review Press
See more...
Widely regarded as an innovative, successful biotech firm, Amgen led its industry in revenue and sales growth in 2007. This book reveals the highs and lows it experienced in the race to develop drugs. It takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its success.
(Hardback, Main)
By: Billy Kenber
ISBN: 9781838850258
Readership/Audience: Tertiary Education
Publication Date: Nov 2021
Publisher: Canongate Books
See more...
An urgent call to build a new model for the pharmaceutical industry, from the multi-award-winning Times journalist.
(Paperback, Export/Airside - Export/Airside/Ireland)
By: Billy Kenber
ISBN: 9781838850265
Readership/Audience: Tertiary Education
Publication Date: Nov 2021
Publisher: Canongate Books
See more...
An urgent call to build a new model for the pharmaceutical industry, from the multi-award-winning Times journalist.
